top of page

Our story

2025

t9g4iskhi2mwgeym9bib.avif

Q2 2025

- Earned a position in the 2025      MedTech Innovator Cohort

Test Tubes With Pipette_edited.jpg

Q3 2025

- Kicked off pre-clinical testing campaign with strong results

2024

implanted2.JPG

Q1 2024

- Prototype flow rate doubled

- Delivery profile decreased by 40%

- Second successful animal study 

a wealthy narwhal with a treasure chest.jpg

Q3 2024

-Closed a fully subscribed seed round

-2 additional U.S. patents were issued

2023

a nerdy sheep studying a science book.jpg

Q2 2023

- First fully functional prototype successfully delivered and operated in an animal

Granted U.S.jpg

Q3-Q4 2023

- First 2 U.S. patents were issued

2022

light bulb giving off red blood cells.jpg

Q1 2022

- Foundation of

Narwhal Medical

Early Prototype Rendering 2.JPG

Q2 2022

- Initial prototypes created demonstrating concept potential

A narwhal laying on top of a dollar sign.jpg

Q3 2022

- Major strategic partner joins Narwhal Medical to create functional

proof-of-concept prototypes

A plain background with a crystal ball with an anatomical human heart inside.jpg

Stay Tuned For More Exciting Developments

Metallic Twirl

Clinical Need

Loïc first observed the shortcomings of current percutaneous ventricular assist devices (pVADs) at a medical conference. He watched a challenging live case where the physicians were unable to deliver a pVAD through an axillary (shoulder) artery access site. Ultimately, the physician took a different treatment approach while also having to deal with closure of the axillary artery large bore access site in the middle of the procedure. Click here for more information about pVAD procedures. 

​

We are creating a pVAD with the smallest delivery profile on the market. This will allow our blood pump to protect the lives of thousands of people every year who are ineligible for treatment with the current pVADs due to blood vessel size or blood vessel disease.

bottom of page